Bendamustine hydrochloride is the generic ingredient in three branded drugs marketed by Cephalon and Eagle Pharms and is included in three NDAs. There are twenty-five patents protecting this compound.
Drug patent litigation for BENDAMUSTINE HYDROCHLORIDE.
This ingredient has one hundred patent family members in thirty-two countries.
Three suppliers are listed for this compound. There are fourteen tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
